Published in Alcohol Clin Exp Res on May 01, 2003
Substance Use Disorders in HIV People of Cameroon | NCT02356185
Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients | NCT01671501
Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr (2007) 3.24
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend (2010) 2.38
Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care (2007) 2.06
Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care STDS (2009) 1.56
Improving health outcomes for youth living with the human immunodeficiency virus: a multisite randomized trial of a motivational intervention targeting multiple risk behaviors. Arch Pediatr Adolesc Med (2009) 1.46
Sero-positive African Americans' beliefs about alcohol and their impact on anti-retroviral adherence. AIDS Behav (2007) 1.42
Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective. J Gen Intern Med (2006) 1.41
Alcohol use and HIV risk behaviors among HIV-infected hospitalized patients in St. Petersburg, Russia. Drug Alcohol Depend (2005) 1.36
Episodic homelessness and health care utilization in a prospective cohort of HIV-infected persons with alcohol problems. BMC Health Serv Res (2006) 1.28
Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis. AIDS Behav (2010) 1.26
Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems. AIDS (2008) 1.25
Alcohol's role in HIV transmission and disease progression. Alcohol Res Health (2010) 1.17
Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol (2009) 1.16
The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients. Addiction (2008) 1.11
Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcohol Depend (2011) 1.10
Medication adherence mediates the relationship between adherence self-efficacy and biological assessments of HIV health among those with alcohol use disorders. AIDS Behav (2007) 1.08
Alcohol consumption trajectory patterns in adult women with HIV infection. AIDS Behav (2013) 1.03
HIV/AIDS, comorbidity, and alcohol: can we make a difference? Alcohol Res Health (2010) 1.02
Comparing alcohol screening measures among HIV-infected and -uninfected men. Alcohol Clin Exp Res (2012) 1.01
Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care (2009) 1.00
Focus on: ethnicity and the social and health harms from drinking. Alcohol Res (2013) 0.99
Association between alcohol use and HIV viral load. J Acquir Immune Defic Syndr (2011) 0.99
Translational methods in biostatistics: linear mixed effect regression models of alcohol consumption and HIV disease progression over time. Epidemiol Perspect Innov (2007) 0.99
The influence of different types of alcoholic beverages on disrupting highly active antiretroviral treatment (HAART) outcome. Alcohol Alcohol (2009) 0.98
Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems. Am J Gastroenterol (2006) 0.98
Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems. AIDS Care (2007) 0.97
Interventions targeting HIV-infected risky drinkers: drops in the bottle. Alcohol Res Health (2010) 0.95
Patient perspectives of an integrated program of medical care and substance use treatment. AIDS Patient Care STDS (2014) 0.94
Recent cigarette smoking and HIV disease progression: no evidence of an association. AIDS Care (2011) 0.92
Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone. Alcohol Clin Exp Res (2011) 0.92
Alcohol consumption is associated with poor health in HIV clinic patient population: a behavioral surveillance study. AIDS Behav (2011) 0.88
Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci (2010) 0.87
Under-reporting of alcohol and substance use versus other psychiatric symptoms in individuals living with HIV. AIDS Care (2011) 0.87
Association of violence victimization with inconsistent condom use in HIV-infected persons. AIDS Behav (2006) 0.86
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol (2016) 0.85
Number of Drinks to "Feel a Buzz" by HIV Status and Viral Load in Men. AIDS Behav (2016) 0.84
Off-premise alcohol sales policies, drinking, and sexual risk among people living with HIV. Am J Public Health (2010) 0.84
The impact of prolonged exposure on PTSD symptoms and associated psychopathology in people living with HIV: a randomized test of concept. AIDS Behav (2012) 0.84
Harm reduction services as a point-of-entry to and source of end-of-life care and support for homeless and marginally housed persons who use alcohol and/or illicit drugs: a qualitative analysis. BMC Public Health (2012) 0.83
Alcohol use disorders and associated factors among people living with HIV who are attending services in south west Ethiopia. BMC Res Notes (2014) 0.83
Perceived benefits and negative consequences of alcohol consumption in women living with HIV: a qualitative study. BMC Public Health (2016) 0.82
Screening patients in busy hospital-based HIV care centers for hazardous and harmful drinking patterns: the identification of an optimal screening tool. J Int Assoc Physicians AIDS Care (Chic) (2009) 0.81
Self-reevaluation as a critical component in sustained viral load change for HIV+ adults with alcohol problems. Ann Behav Med (2010) 0.80
The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques. AIDS Res Hum Retroviruses (2014) 0.80
Perceptions of alcohol risk among individuals living with HIV. AIDS Care (2011) 0.79
Brief screening for alcohol use disorders in HIV primary care. HIV Clin (2011) 0.79
Anxiety sensitivity and hazardous drinking among persons living with HIV/AIDS: An examination of the role of emotion dysregulation. Addict Behav (2016) 0.78
Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics. Addict Sci Clin Pract (2016) 0.78
The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV. AIDS Behav (2016) 0.77
Substance use during sexual and physical assault in HIV-infected persons. Violence Vict (2007) 0.77
Effects of Heavy Drinking on T-Cell Phenotypes Consistent with Immunosenescence in Untreated HIV Infection. Alcohol Clin Exp Res (2016) 0.76
Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012. Alcohol Alcohol (2014) 0.76
Alcohol and associated characteristics among older persons living with human immunodeficiency virus on antiretroviral therapy. Subst Abus (2014) 0.76
Alcohol abuse and HIV infection: role of DRD2. Curr HIV Res (2014) 0.76
The Prevalence of HIV Risk Behaviors among Felony Drug Court Participants. Drug Court Rev (2012) 0.75
Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients. Drug Alcohol Depend (2016) 0.75
Pain and Mortality Risk in a Cohort of HIV-Infected Persons with Alcohol Use Disorders. AIDS Behav (2016) 0.75
Alcohol use disorders among people living with HIV/AIDS in Southern Brazil: prevalence, risk factors and biological markers outcomes. BMC Infect Dis (2017) 0.75
HIV Patients' Preference for Integrated Models of Addiction and HIV Treatment in Vietnam. J Subst Abuse Treat (2016) 0.75
Behavioral Interventions Targeting Alcohol Use Among People Living with HIV/AIDS: A Systematic Review and Meta-Analysis. AIDS Behav (2017) 0.75
Barriers and facilitators of the HIV care continuum in Southern New England for people with drug or alcohol use and living with HIV/AIDS: perspectives of HIV surveillance experts and service providers. Addict Sci Clin Pract (2017) 0.75
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Expanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med (2005) 8.49
The survival benefits of AIDS treatment in the United States. J Infect Dis (2006) 7.08
The lifetime cost of current human immunodeficiency virus care in the United States. Med Care (2006) 5.87
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. N Engl J Med (2006) 5.62
Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med (2006) 5.53
Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr (2009) 5.40
The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One (2010) 4.75
Brief intervention for medical inpatients with unhealthy alcohol use: a randomized, controlled trial. Ann Intern Med (2007) 4.73
Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Ann Intern Med (2013) 4.43
When to start antiretroviral therapy in resource-limited settings. Ann Intern Med (2009) 4.31
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol (2004) 4.20
Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ (2011) 4.12
Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis (2010) 3.96
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS (2010) 3.93
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis (2009) 3.89
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr (2006) 3.39
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis (2009) 3.30
Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res (2004) 3.24
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med (2013) 3.10
Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med (2011) 3.08
Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis (2008) 2.96
Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr (2007) 2.91
Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med (2004) 2.72
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med (2003) 2.48
Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis (2005) 2.47
Optimizing resource allocation in United States AIDS drug assistance programs. Clin Infect Dis (2006) 2.45
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis. AIDS (2005) 2.39
Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med (2011) 2.36
HIV/AIDS, undernutrition, and food insecurity. Clin Infect Dis (2009) 2.33
Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing. Arch Intern Med (2002) 2.30
Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. S Afr Med J (2008) 2.30
Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis (2010) 2.28
HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies. J Acquir Immune Defic Syndr (2009) 2.24
HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme. Antivir Ther (2009) 2.18
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal. PLoS Med (2009) 2.13
Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis. PLoS Med (2010) 2.10
Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire. PLoS One (2010) 2.05
A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference. Am J Epidemiol (2017) 2.05
Evaluation of risk factors associated with recurrent obstruction in cats treated medically for urethral obstruction. J Am Vet Med Assoc (2013) 1.96
Randomized controlled trial of proactive web-based alcohol screening and brief intervention for university students. Arch Intern Med (2009) 1.95
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Med Decis Making (2002) 1.94
Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis (2012) 1.90
Cigarette smoking in relation to depression: historical trends from the Stirling County Study. Am J Psychiatry (2003) 1.90
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med (2015) 1.89
Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction (2004) 1.88
Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses (2004) 1.88
A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther (2005) 1.82
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clin Infect Dis (2012) 1.80
Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. Clin Infect Dis (2004) 1.78
Refusing HIV testing in an urgent care setting: results from the "Think HIV" program. AIDS Patient Care STDS (2006) 1.76
Statistical methods in the journal. N Engl J Med (2005) 1.76
Cost-effectiveness of genotype testing for primary resistance in Brazil. J Acquir Immune Defic Syndr (2015) 1.73
Including all individuals is not enough: lessons for intention-to-treat analysis. Clin Trials (2012) 1.71
Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis (2007) 1.70
Longitudinal associations between binge eating and overeating and adverse outcomes among adolescents and young adults: does loss of control matter? JAMA Pediatr (2013) 1.69
Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis (2003) 1.69
The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire. Antivir Ther (2007) 1.68
Bias due to missing exposure data using complete-case analysis in the proportional hazards regression model. Stat Med (2003) 1.68
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. J Acquir Immune Defic Syndr (2011) 1.67
Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst (2003) 1.66
Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count. S Afr Med J (2011) 1.65
AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire. Clin Infect Dis (2012) 1.64
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers. PLoS One (2011) 1.63
The lifetime medical cost savings from preventing HIV in the United States. Med Care (2015) 1.61
Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr (2007) 1.61
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV. AIDS (2008) 1.59
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr (2010) 1.57
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age. AIDS (2012) 1.57
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial. Clin Infect Dis (2007) 1.57
Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med (2005) 1.56
Acculturation status and heavy alcohol use among Mexican American college students: investigating the moderating role of gender. Addict Behav (2006) 1.56
A prospective study of the effect of childbearing on weight gain in African-American women. Obes Res (2003) 1.56
Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India. Clin Infect Dis (2010) 1.55
Addressing alcohol problems in primary care: a cluster randomized, controlled trial of a systems intervention. The screening and intervention in primary care (SIP) study. Ann Intern Med (2003) 1.54
Frequent HIV testing among participants of a routine HIV testing program. Virulence (2010) 1.53
What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis. PLoS Med (2012) 1.53
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age. AIDS (2015) 1.49
Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry (2002) 1.49
Efficacy of a clinical decision-support system in an HIV practice: a randomized trial. Ann Intern Med (2012) 1.48
Perceptions of racial discrimination and the risk of preterm birth. Epidemiology (2002) 1.48
Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS One (2010) 1.46
The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug Alcohol Depend (2005) 1.45
Do brief measures of readiness to change predict alcohol consumption and consequences in primary care patients with unhealthy alcohol use? Alcohol Clin Exp Res (2007) 1.44
The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clin Infect Dis (2007) 1.43
Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. Am J Public Health (2005) 1.41
Prospective association of common eating disorders and adverse outcomes. Pediatrics (2012) 1.41
Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol (2007) 1.41
The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS (2012) 1.40
Primary medical care and reductions in addiction severity: a prospective cohort study. Addiction (2005) 1.40
Predicting virologic failure in an HIV clinic. Clin Infect Dis (2010) 1.39
The severity of unhealthy alcohol use in hospitalized medical patients. The spectrum is narrow. J Gen Intern Med (2006) 1.38
Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature. Clin Infect Dis (2010) 1.38
Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. Arch Gen Psychiatry (2002) 1.38
Alcohol use and HIV risk behaviors among HIV-infected hospitalized patients in St. Petersburg, Russia. Drug Alcohol Depend (2005) 1.36
Handling missing data in RCTs; a review of the top medical journals. BMC Med Res Methodol (2014) 1.35